5008/5008S therapy system


The number of patients requiring haemodialysis is continuously increasing, with a growing share of medically challenging patients combined with limited financial and human resources.

Fresenius Medical Care's commitment to continuous improvement and development of new dialysis therapies and products that aims to meet the ever-changing challenges of dialysis therapy has led to the development of the 5008/5008S therapy system.

The 5008/5008S therapy system offers, for the first time, the dialysis therapy of choice – ONLINE haemodiafiltration (HDF)1-6 – with easy handling and thoughtful use of dialysis-relevant resources. It is a highly integrated system, built for sustainable dialysis – today and in the future.

Optimal therapy for your patients:

  • ONLINE HDF – the dialysis therapy of choice1-6
  • Monitoring of dialysis dose by OCM® (online clearance monitoring and plasma sodium measurement)
  • Absolute patient safety including ultrapure dialysis fluid (DIASAFE®plus filter)
  • Single-needle method
  • Long-term patient surveillance

Optimal handling for all users:

  • Well-designed user interface with large, clear touch-screen monitor
  • Flexible, safe and easy data management including device setting using a patient card (offline) and/or network integration (online)
  • Optimised ergonomics

Optimal use of resources:

  • Efficient and sustainable
  • Online priming bolus and substitution reinfusion offering complete elimination of saline and irrigation bags
  • AutoFlow and Ecoflow – saving water, concentrates and energy

Optional therapeutic tools - that are operated via the touch screen monitor are also available. These fully integrated options include:

  • Blood pressure monitor (BPM)
  • Blood temperature monitor (BTM)
  • Blood volume monitor (BVM)
  • Therapy Data Management System (TDMS)


  1. Locatelli F et al. J Am Soc Nephrol 2010:21:1798–807.
  2. Carracedo J et al. J Am Soc Nephrol 2006;17:2315–21.
  3. Gerdemann A et al. Nephrol Dial Tranplant 2002;17:1045–9.
  4. Canaud B. Contrib Nephrol 2007;158:216–24.
  5. Jirka T et al. Kidney Int 2006;70:1524–5.
  6. Canaud B et al. Kidney Int 2006;69:2087–93.

explore the 5008-2